Incidence of synchronous liver metastases in patients with colorectal cancer in relationship to clinico-pathologic characteristics. Results of a German prospective multicentre observational study

被引:56
|
作者
Mantke, R. [1 ]
Schmidt, U. [1 ,2 ]
Wolff, S. [1 ]
Kube, R. [1 ]
Lippert, H. [1 ]
机构
[1] Univ Magdeburg, Dept Surg, Inst Qual Control Surg, D-39106 Magdeburg, Germany
[2] StatConsult Magdeburg, Magdeburg, Germany
来源
EJSO | 2012年 / 38卷 / 03期
关键词
Liver metastases; Colo-rectal cancer; APPENDICEAL MUCINOUS NEOPLASMS; HEPATIC RESECTION; VENOUS INVASION; RECTAL-CANCER; MANAGEMENT; CARCINOMA; SURVIVAL; IMPACT; EPIDEMIOLOGY; RECURRENCE;
D O I
10.1016/j.ejso.2011.12.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The aim of this prospective observational multicentre study was to evaluate the incidence of synchronous liver metastases in colon and rectal cancer and to determine clinico-pathologic factors of the colorectal cancer that influenced the development of synchronous liver metastases. Methods: Of 48,894 patients with colorectal cancer and who underwent surgery between January 2000 and December 2004, 7209 developed hepatic metastases and were analyzed. Results: Synchronous liver metastases occurred in 14.7% of the colorectal cancer cases. Colon cancer (15.4%) led significantly more frequently to haematogenous spread to the liver than rectal cancer (13.5%) in a univariate approach. The N, V, and T stage, as well as the number of metastatic-involved local lymph nodes independently influenced the frequency of synchronous liver metastases in colon and rectal cancer in a multivariate analysis. Localization of the cancer in the colon led to a different number of synchronous liver metastases. Localization of the rectal cancer did not influence the rate of synchronous liver metastases. In the case of synchronous liver metastases, patients with colon cancer had significantly more peritoneal metastases (17.9 vs. 9.15%) but less lung (9.7 vs. 14%) and bone (0.7 vs. 1.6%) metastases. Simultaneous curative liver resections were done in 7% of colon cancer cases and in 8.8% of rectal cancer cases. Conclusion: In this national study the incidence of synchronous liver metastases in colon and rectal cancer were different. Independent factors leading to synchronous liver metastases could be identified. Venous infiltration seems to be important for the development of distant metastases. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:259 / 265
页数:7
相关论文
共 46 条
  • [1] Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study
    Vayrynen, V.
    Wirta, E. -V.
    Seppala, T.
    Sihvo, E.
    Mecklin, J. -P.
    Vasala, K.
    Kellokumpu, I.
    BJS OPEN, 2020, 4 (04): : 685 - 692
  • [2] Simultaneous resection of colorectal cancer and synchronous liver metastases is safe for properly selected elderly patients: A retrospective study
    Guo, Yulin
    Hu, Shun
    Cao, Feng
    Liu, Dongbin
    Li, Fei
    JOURNAL OF BUON, 2020, 25 (05): : 2192 - 2198
  • [3] Clinical added value of MRI to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): study protocol for an international multicentre prospective diagnostic accuracy study
    Gorgec, B.
    Hansen, I
    Kemmerich, G.
    Syversveen, T.
    Abu Hilal, M.
    Belt, E. J. T.
    Bisschops, R. H. C.
    Bollen, T. L.
    Bosscha, K.
    Burgmans, M. C.
    Cappendijk, V
    De Boer, M. T.
    D'Hondt, M.
    Edwin, B.
    Gielkens, H.
    Grunhagen, D. J.
    Gillardin, P.
    Gobardhan, P. D.
    Hartgrink, H. H.
    Horsthuis, K.
    Kok, N. F. M.
    Kint, P. A. M.
    Kruimer, J. W. H.
    Leclercq, W. K. G.
    Lips, D. J.
    Lutin, B.
    Maas, M.
    Marsman, H. A.
    Morone, M.
    Pennings, J. P.
    Peringa, J.
    Te Riele, W. W.
    Vermaas, M.
    Wicherts, D.
    Willemssen, F. E. J. A.
    Zonderhuis, B. M.
    Bossuyt, P. M. M.
    Swijnenburg, R. J.
    Fretland, A. A.
    Verhoef, C.
    Besselink, M. G.
    Stoker, J.
    BMC CANCER, 2021, 21 (01)
  • [4] Serum neutrophil gelatinase-associated lipocalin in patients with colorectal liver metastases: preliminary results of an exploratory prospective study
    Marti, Josep
    Fuster, Josep
    Hotter, Gina
    Sola, Anna M.
    Deulofeu, Ramon
    Marta Modolo, Maria
    Antonio Loera, Marco
    Ferrer, Joana
    Fondevila, Constantino
    Carlos Garcia-Valdecasas, Juan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2010, 25 (01) : 21 - 26
  • [5] Long-term results of liver-first approach strategy in patients with advanced synchronous liver metastases from colorectal cancer
    Fonollosa, Eric Herrero
    Recasens, Maria Galofre
    Pinedo, Alba Zarate
    Domingo, Maria Isabel Garcia
    Lasa, Judith Camps
    Aranda, Fernando Pardo
    Alvarez, Francisco Espin
    Andorra, Esteban Cugat
    CIRUGIA ESPANOLA, 2023, 101 (05): : 341 - 349
  • [6] Open and/or laparoscopic one-stage resections of primary colorectal cancer and synchronous liver metastases An observational study
    Nozawa, Hiroaki
    Ishizawa, Takeaki
    Yasunaga, Hideo
    Ishii, Hiroaki
    Sonoda, Hirofumi
    Emoto, Shigenobu
    Murono, Koji
    Sasaki, Kazuhito
    Kawai, Kazushige
    Akamatsu, Nobuhisa
    Kaneko, Junichi
    Arita, Junichi
    Hasegawa, Kiyoshi
    Ishihara, Soichiro
    MEDICINE, 2021, 100 (11) : E25205
  • [7] A multicentre, international, observational study on transarterial chemoembolisation in colorectal cancer liver metastases: Design and rationale of CIREL
    Pereira, Philippe L.
    Arnold, Dirk
    de Baere, Thierry
    Gomez, Fernando
    Helmberger, Thomas
    Iezzi, Roberto
    Maleux, Geert
    Prenen, Hans
    Sangro, Bruno
    Nordlund, Anders
    Zeka, Bleranda
    Bauer, Robert
    Kaufmann, Nathalie
    Pellerin, Olivier
    Taieb, Julien
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (08) : 857 - 861
  • [8] Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study
    Lurvink, R. J.
    Bakkers, C.
    Rijken, A.
    van Erning, F. N.
    Nienhuijs, S. W.
    Burger, J. W.
    Creemers, G. J.
    Verhoef, C.
    Lemmens, V. E.
    De Hingh, I. H.
    EJSO, 2021, 47 (05): : 1026 - 1033
  • [9] Deep radiomics-based fusion model for prediction of bevacizumab treatment response and outcome in patients with colorectal cancer liver metastases: a multicentre cohort study
    Zhou, Shizhao
    Sun, Dazhen
    Mao, Wujian
    Liu, Yu
    Cen, Wei
    Ye, Lechi
    Liang, Fei
    Xu, Jianmin
    Shi, Hongcheng
    Ji, Yuan
    Wang, Lisheng
    Chang, Wenju
    ECLINICALMEDICINE, 2023, 65
  • [10] Hepatic Arterial Infusion with Irinotecan in Patients with Liver Metastases of Colorectal Cancer: Results of an Extended Phase I Study
    Eichler, K.
    Dufas, T.
    Hammerstingl, R.
    Gruber-Rouh, T.
    Vogl, T. J.
    Zangos, S.
    CHEMOTHERAPY, 2013, 59 (01) : 66 - 73